OncoImmunology
Volume 7, 2018 - Issue 4
Open access
3,294
Views
15
CrossRef citations to date
0
Altmetric
Original Research
S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity
Jinhua ZhangKey Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, Chinahttps://orcid.org/0000-0003-3291-8126View further author information
, Kun SongKey Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China;University of Chinese Academy of Sciences, Beijing, ChinaView further author information
, Jun WangDepartment of Immunobiology and Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USAView further author information
, Yanan LiKey Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China;University of Chinese Academy of Sciences, Beijing, ChinaView further author information
, Shuangqing LiuKey Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China;University of Chinese Academy of Sciences, Beijing, ChinaView further author information
, Chengliang DaiKey Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China;University of Chinese Academy of Sciences, Beijing, ChinaView further author information
, Lieping ChenDepartment of Immunobiology and Yale Cancer Center, Yale University School of Medicine, New Haven, CT, USAhttps://orcid.org/0000-0002-6825-3069View further author information
, Shengdian WangKey Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, ChinaView further author information
& Zhihai QinKey Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China;Medical Research Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: e1296996
|
Received 31 Oct 2016, Accepted 14 Feb 2017, Published online: 23 Jan 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.